ID   GG
AC   CVCL_A1IB
DR   Wikidata; Q102113870
RX   DOI=10.5282/edoc.3898;
RX   PubMed=9384677;
RX   PubMed=10359208;
RX   PubMed=12836015;
RX   PubMed=15706405;
CC   HLA typing: A*02,32; B*07,27; C*01,07; DQA1*04:01,05:01; DQB1*03:01,04; DRB1*08,11 (PubMed=10359208).
CC   HLA typing: A*02,32; B*07,27; DQB1*03,04:02; DRB1*08:01,11:03 (PubMed=12836015).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
CH   CVCL_E6X6 ! GG8
//
RX   PubMed=15706405; DOI=10.3892/or.13.3.375;
RA   Euer, Nicole Isabel
RA   Kaul, Sepp
RA   Deissler, Helmut
RA   Mobus, Volker Jochen
RA   Zeillinger, Robert
RA   Weidle, Ulrich H.
RT   "Identification of L1CAM, Jagged2 and neuromedin U as ovarian
RT   cancer-associated antigens.";
RL   Oncol. Rep. 13:375-387(2005).
//
RX   PubMed=12836015; DOI=10.1007/s00432-003-0445-7;
RA   Kayser, Simone
RA   Watermann, Iris
RA   Rentzsch, Christine
RA   Weinschenk, Toni
RA   Wallwiener, Diethelm
RA   Guckel, Brigitte
RT   "Tumor-associated antigen profiling in breast and ovarian cancer:
RT   mRNA, protein or T cell recognition?";
RL   J. Cancer Res. Clin. Oncol. 129:397-409(2003).
//
RX   DOI=10.5282/edoc.3898;
RA   Euer, Nicole Isabel
RT   "Identification of target genes for the therapy and diagnosis of
RT   ovarian carcinoma.";
RL   Thesis PhD (2005); Ludwig Maximilians University of Munich; Munich; Germany.
//
RX   PubMed=9384677;
RA   Guckel, Brigitte
RA   Lindauer, Markus
RA   Rudy, Wolfgang
RA   Habicht, Annette
RA   Siebels, Michael
RA   Kaul, Sepp
RA   Bastert, Gunther
RA   Meuer, Stefan Carl
RA   Moebius, Ulrich
RT   "CD80-transfected human breast and ovarian tumor cell lines: improved
RT   immunogenicity and induction of cytolytic CD8+ T lymphocytes.";
RL   Cytokines Mol. Ther. 1:211-221(1995).
//
RX   PubMed=10359208; DOI=10.1038/sj.cgt.7700050;
RA   Guckel, Brigitte
RA   Meyer, Geeske C.
RA   Rudy, Wolfgang
RA   Batrla, Richard
RA   Meuer, Stefan Carl
RA   Bastert, Gunther
RA   Wallwiener, Diethelm
RA   Moebius, Ulrich
RT   "Interleukin-12 requires initial CD80-mediated T-cell activation to
RT   support immune responses toward human breast and ovarian carcinoma.";
RL   Cancer Gene Ther. 6:228-237(1999).
//